Moreover, the difference between the impact of Meth and neuroHIV on cortical astrocytes also suggests the diversities in the distinct structure and signaling pathways coupled with TAAR1 and chemokine receptors, respectively, which could shed light on the development of new therapeutic strategy for treating MUD and HAND. The gene discussed is TAAR1; the disease is HIV-associated neurocognitive disorder.